Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CTNM2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in CONTINEUM THERAPEUTICS INC
Yes. Vanguard Capital Management holds 1,321,356 shares of CTNM (Contineum Therapeutics), worth $21.7M, as of its Q2 2026 13F filing. It increased the position by 107,183 shares (+8.8%) from Q1 2026. Vanguard Capital Management has held CTNM in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$21.7M
Current Shares
1.3M
Total Value Change
+$5.8M
Total Shares Change
+107,183
Quarter-by-Quarter History
Other major holders of CTNM: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN TEMPLETON INC